LifeMD, Inc. LFMD
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.55% | -1.42% | 3.84% | 12.95% | -5.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.55% | -1.42% | 3.84% | 12.95% | -5.59% |
| Cost of Revenue | -22.73% | -27.17% | -28.20% | 47.76% | 36.10% |
| Gross Profit | -0.43% | 3.48% | 11.15% | 9.34% | -10.06% |
| SG&A Expenses | 11.10% | 21.20% | -0.36% | 3.02% | -14.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.77% | 39.94% | 12.64% | 43.93% | 49.33% |
| Total Operating Expenses | 5.93% | 13.49% | -4.03% | 8.51% | -8.58% |
| Operating Income | -203.79% | -655.61% | 77.34% | 50.72% | 44.98% |
| Income Before Tax | -135.53% | -439.24% | 80.32% | 25.63% | 37.30% |
| Income Tax Expenses | -- | -- | -97.68% | -27.27% | -- |
| Earnings from Continuing Operations | -135.53% | -439.24% | 82.04% | 25.71% | 37.30% |
| Earnings from Discontinued Operations | -- | -- | 1,373.96% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 106.64% | -292.66% | -104.41% |
| Net Income | -337.36% | -4,727.31% | 504.23% | 18.29% | 67.89% |
| EBIT | -203.79% | -655.61% | 77.34% | 50.72% | 44.98% |
| EBITDA | -216.82% | -744.14% | -154.87% | 60.07% | 45.14% |
| EPS Basic | -204.63% | -813.90% | 402.95% | 23.20% | 61.67% |
| Normalized Basic EPS | -72.44% | -223.48% | -- | 44.98% | 31.68% |
| EPS Diluted | -204.63% | -813.90% | 392.57% | 23.08% | 62.03% |
| Normalized Diluted EPS | -72.44% | -223.48% | -- | 44.98% | 31.68% |
| Average Basic Shares Outstanding | 7.63% | 9.74% | 10.82% | 9.86% | 7.49% |
| Average Diluted Shares Outstanding | 7.63% | 9.74% | 10.82% | 9.86% | 7.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.77% | 0.98% | -- | -0.22% | -2.11% |